The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.
More than 20% of Hawai‘i residents are over the age of 65 years old, possibly making them more at risk for eye diseases, ...
Ocugen (OCGN) announced that dosing is complete, ahead of schedule in the Phase 2 portion of the Phase 1/2 ArMaDa clinical trial for OCU410-a ...
Here's what macular degeneration is, what causes it and how you can expect it to be treated if it affects you or a loved one.
Can supplementing with vitamins and minerals protect your eye health? Learn more about the role of nutrients in age-related ...
In this Healio Video Perspective from Retina 2025, Ashkan M. Abbey, MD, discusses 1-year results from the phase 2 DAVIO 2 clinical trial investigating EYP-1901 in previously treated wet age-related ...
Regeneron Pharmaceuticals has announced results from the phase 3 QUASAR trial and its extension study of the phase 3 PULSAR ...
D Molecular (FDMT) presented 52-week wet age-related macular degeneration Phase IIb results at this weekend’s Angiogenesis, Exudation, and ...
2d
GlobalData on MSNRegeneron’s macular oedema therapy shows promise in Phase III trialIn the trial, subjects treated with the Eylea HD 8mg injection every eight weeks showed non-inferior visual acuity gains.
These are the best vitamins and supplements for eye health, which are great for supporting your vision and helping you take ...
As people get older, two of the biggest health concerns are dementia and eye diseases like macular degeneration and cataracts ...
For those who smoke, this long-term habit can damage parts of your eye, contributing to serious conditions such as macular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results